Functional characterization of a promoter polymorphism that drives ACSL5 gene expression in skeletal muscle and associates with diet-induced weight loss

FASEB Journal

Volumn 23, Issue 6, 2009, Pages 1705-1709

  Teng, Allen C T ^a,b   Adamo, Kristi ^b,c   Tesson, Frédérique ^a,b   Stewart, Alexandre F R ^a,b  

^a UNIVERSITY OF OTTAWA   (Canada)

^b UNIVERSITY OF OTTAWA HEART INSTITUTE   (Canada)

^c CHILDREN S HOSPITAL OF EASTERN ONTARIO   (Canada)

Author keywords

Fatty acid; Genetics; MyoD; Obesity

Indexed keywords

LONG CHAIN FATTY ACID COENZYME A LIGASE; LONG CHAIN FATTY ACID COENZYME A LIGASE LONG CHAIN 5; MYOD PROTEIN; UNCLASSIFIED DRUG; ACSL5 PROTEIN, HUMAN; HYBRID PROTEIN;

ALLELE; ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; DIETARY INTAKE; E BOX ELEMENT; GEL MOBILITY SHIFT ASSAY; GENE EXPRESSION; HETEROZYGOTE; HUMAN; HUMAN CELL; MYOBLAST; PRIORITY JOURNAL; PROMOTER REGION; SINGLE NUCLEOTIDE POLYMORPHISM; SKELETAL MUSCLE; TRANSCRIPTION INITIATION; UPREGULATION; WEIGHT REDUCTION; ADULT; ANIMAL; CAUCASIAN; FEMALE; GENETIC POLYMORPHISM; GENETICS; LOW CALORY DIET; METABOLISM; MOLECULAR GENETICS; MOUSE; NUCLEOTIDE SEQUENCE; OBESITY; PHYSIOLOGY;

ADULT; ALLELES; ANIMALS; BASE SEQUENCE; COENZYME A LIGASES; DIET, REDUCING; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HUMANS; MICE; MOLECULAR SEQUENCE DATA; MUSCLE, SKELETAL; MYOD PROTEIN; OBESITY; POLYMORPHISM, GENETIC; PROMOTER REGIONS, GENETIC; RECOMBINANT FUSION PROTEINS; WEIGHT LOSS;

EID: 67649321758     PISSN: 08926638     EISSN: 15306860     Source Type: Journal    
DOI: 10.1096/fj.08-120998     Document Type: Article

References (22)

1. Poirier, P., Giles, T. D., Bray, G. A., Hong, Y., Stern, J. S., Pi-Sunyer, F. X., and Eckel, R. H. (2006) Obesity and cardiovascular disease: pathophysiology, evaluation, and effect of weight loss. Arterioscler. Thromb. Vasc. Biol. 26, 968-976 (Pubitemid 43732100)
2. Kahn, S. E., Hull, R. L., and Utzschneider, K. M. (2006) Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature 444, 840-846 (Pubitemid 46024990)
3. Willig, T. N., Carlier, L., Legrand, M., Riviere, H., and Navarro, J. (1993) Nutritional assessment in Duchenne muscular dystrophy. Dev. Med. Child Neurol. 35, 1074-1082 (Pubitemid 23346432)
4. Calle, E. E., Rodriguez, C., Walker-Thurmond, K., and Thun, M. J. (2003) Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N. Engl. J. Med. 348, 1625-1638 (Pubitemid 36459468)
5. Yamashita, Y., Kumabe, T., Cho, Y. Y., Watanabe, M., Kawagishi, J., Yoshimoto, T., Fujino, T., Kang, M. J., and Yamamoto, T. T. (2000) Fatty acid induced glioma cell growth is mediated by the acyl-CoA synthetase 5 gene located on chromosome 10q25.1- q25.2, a region frequently deleted in malignant gliomas. Oncogene 19, 5919-5925 (Pubitemid 32005373)
6. Mashek, D. G., Li, L. O., and Coleman, R. A. (2006) Rat long-chain acyl-CoA synthetase mRNA, protein, and activity vary in tissue distribution and in response to diet. J. Lipid Res. 47, 2004-2010
7. Adamo, K. B., Dent, R., Langefeld, C. D., Cox, M., Williams, K., Carrick, K. M., Stuart, J. S., Sundseth, S. S., Harper, M. E., McPherson, R., and Tesson, F. (2007) Peroxisome proliferator-activated receptor gamma 2 and acyl-CoA synthetase 5 polymorphisms influence diet response. Obesity 15, 1068-1075 (Pubitemid 46932460)
8. Mashek, D. G., McKenzie, M. A., Van Horn, C. G., and Coleman, R. A. (2006) Rat long chain acyl-CoA synthetase 5 increases fatty acid uptake and partitioning to cellular triacylglycerol in McArdle-RH7777 cells. J. Biol. Chem. 281, 945-950
9. Zhou, Y., Abidi, P., Kim, A., Chen, W., Huang, T. T., Kraemer, F. B., and Liu, J. (2007) Transcriptional activation of hepatic ACSL3 and ACSL5 by oncostatin m reduces hypertriglyceridemia through enhanced beta-oxidation. Arterioscler. Thromb. Vasc. Biol. 27, 2198-2205 (Pubitemid 350287250)
10. Maeda, T., Chapman, D. L., and Stewart, A. F. (2002) Mammalian vestigial-like 2, a cofactor of TEF-1 and MEF2 transcription factors that promotes skeletal muscle differentiation. J. Biol. Chem. 277, 48889-48898 (Pubitemid 35470858)
11. Chen, H. H., Maeda, T., Mullett, S. J., and Stewart, A. F. (2004) Transcription cofactor Vgl-2 is required for skeletal muscle differentiation. Genesis 39, 273-279 (Pubitemid 39201549)
12. Rhodes, S. J., and Konieczny, S. F. (1989) Identification of MRF4: a new member of the muscle regulatory factor gene family. Genes Dev. 3, 2050-2061 (Pubitemid 20023230)
13. Rudnicki, M. A., Schnegelsberg, P. N., Stead, R. H., Braun, T., Arnold, H. H., and Jaenisch, R. (1993) MyoD or Myf-5 is required for the formation of skeletal muscle. Cell 75, 1351-1359 (Pubitemid 24021909)
14. Wright, W. E., Sassoon, D. A., and Lin, V. K. (1989) Myogenin, a factor regulating myogenesis, has a domain homologous to MyoD. Cell 56, 607-617
15. Zhuang, Y., Kim, C. G., Bartelmez, S., Cheng, P., Groudine, M., and Weintraub, H. (1992) Helix-loop-helix transcription factors E12 and E47 are not essential for skeletal or cardiac myogenesis, erythropoiesis, chondrogenesis, or neurogenesis. Proc. Natl. Acad. Sci. U. S. A. 89, 12132-12136 (Pubitemid 23004799)
16. Dodou, E., Xu, S. M., and Black, B. L. (2003) mef2c is activated directly by myogenic basic helix-loop-helix proteins during skeletal muscle development in vivo. Mech. Dev. 120, 1021-1032 (Pubitemid 37205045)
17. Skerjanc, I. S., and McBurney, M. W. (1994) The E box is essential for activity of the cardiac actin promoter in skeletal but not in cardiac muscle. Dev. Biol. 163, 125-132
18. Donoviel, D. B., Shield, M. A., Buskin, J. N., Haugen, H. S., Clegg, C. H., and Hauschka, S. D. (1996) Analysis of muscle creatine kinase gene regulatory elements in skeletal and cardiac muscles of transgenic mice. Mol. Cell. Biol. 16, 1649-1658
19. Weintraub, H., Davis, R., Lockshon, D., and Lassar, A. (1990) MyoD binds cooperatively to two sites in a target enhancer sequence: occupancy of two sites is required for activation. Proc. Natl. Acad. Sci. U. S. A. 87, 5623-5627 (Pubitemid 20240339)
20. Haupt, A., Thamer, C., Machann, J., Kirchhoff, K., Stefan, N., Tschritter, O., Machicao, F., Schick, F., Haring, H. U., and Fritsche, A. (2008) Impact of variation in the FTO gene on whole body fat distribution, ectopic fat, and weight loss. Obesity 16, 1969-1972
21. Muller, T. D., Hinney, A., Scherag, A., Nguyen, T. T., Schreiner, F., Schafer, H., Hebebrand, J., Roth, C. L., and Reinehr, T. (2008) "Fat mass and obesity associated" gene (FTO): no significant association of variant rs9939609 with weight loss in a lifestyle intervention and lipid metabolism markers in German obese children and adolescents. BMC Med. Genet. 9, 85
22. Cecil, J., Tavendale, R., Watt, P., Hetherington, M., and Palmer, C. (2008) An obesity-associated FTO gene variant and increased energy intake in children. New Engl. J. Med. 359, 2558-2566